Princeton Eye Group News Archives | Page 2 of 3 | The Princeton Eye Group


  Contact : (609) 921-9437

All Posts in Category: Princeton Eye Group News

Concert of Hope on November 12, 2019

Our “A Concert for Hope” raised nearly $25k to help save lives and provide vital eye care to the impoverished nation of Burundi, Africa and specifically the Kibuye Eye Clinic. The sold-out show took place on Tuesday, November 12th at Hopewell Theatre and featured the musical talents of several Princeton Eye Group doctors and staff. Thanks to all of our sponsors and attendees as well as performers PEG All-Stars, Project One and headliner Jill Sobule.

Read More

The AcrySof IQ PanOptix Trifocal intraocular lens implant by Alcon

trifocal interocular lens implant

The doctors of the Princeton Eye Group pride themselves on always being on the forefront of technology. This week our doctors were among the very first in the country to offer and implant the AcrySof IQ PanOptix Trifocal intraocular lens implant by Alcon. This is the first and only FDA-approved trifocal lens implant, offering an exceptional range of distance, intermediate, and near vision to further reduce the need for glasses after cataract surgery.

Read Alcon’s press release on this exciting new development in ophthalmology here.

Read More

Lindsay Sobel’s Inspiring Story

With the help of Novartis, the Princeton Eye Group had the honor to hear from guest speaker (and PEG employee!) Lindsay Sobel last week.

Lindsay’s talk “All the things eye didn’t know” detailed her journey over the last several years as a patient through various doctors’ offices. Although Lindsay’s battle ultimately resulted in the loss of her eye, she is using her experience to help educate others.

Her talk was both moving and inspiring for our doctors and staff, helping everyone to gain perspective on how each interaction, no matter how trivial, can make or break the patient’s experience. We look forward to hearing more of Lindsay’s brave journey.

Read More

We are thrilled to welcome our new Ophthalmologist, Dr. Peter Murr!

We are thrilled to welcome our new Ophthalmologist, Dr. Peter Murr! Dr. Murr provides comprehensive ophthalmology services, cataract surgery, in-office laser and minor procedures, speaks intermediate Mandarin, and is bilingual English/Spanish. In his free time, he enjoys reading, soccer, and tennis.

Please be sure to welcome Dr. Murr the next time you’re in the office!

Read More

Phyllis Rakow inducted into the National Academy of Opticianry’s Hall of Fame

Phyllis Rakow, our Director of Contact Lens Services, was inducted into the
National Academy of Opticianry‘s Hall of Fame! She was inducted at Vision Expo East in New York City on March 23. Phyllis is certified as an Ophthalmic Medical Technologist and Master of Contact Lens Technology and was honored for her contributions as a speaker, author, and educator in the field of contact lenses.

She also recently celebrated her 20th anniversary with Princeton Eye Group. We couldn’t be prouder of Phyllis and all of her achievements!

Read More

Phyllis Rakow Selected for the National Academy of Opticianry Hall of Fame

We are excited to announce that Princeton Eye Group’s very own Phyllis Rakow, COMT, is being recognized yet again for her outstanding contributions in her field of eye care.

The National Academy of Opticianry will be inducting her into their Hall of Fame at the upcoming Vision Expo East meeting this spring. Here’s a page from the NAO newsletter.

phyllis rakow NAO hall of fame

A well deserved honor. Congratulations Phyllis!

Read More

Dr. Miedziak sets the mark as pioneer in corneal cross-linking for keratoconus

Exciting news that will forever change the way we approach and treat corneal weakening diseases such as keratoconus and corneal ectasia! The FDA has approved the Avedro KXL Corneal Collagen Cross-Linking System (www.avedro.com), and the Princeton Eye Group will be only one of a handful of sites in the country to launch this technology. Dr. Miedziak was one of only two investigators in NJ participating in the FDA-monitored trials, and by so doing, learned how this technology can often arrest keratoconus and corneal ectasia. There were some stunning success stories in patients who previously could not be treated. This specialized non-incisional technique utilizes riboflavin assisted UV-light emission cross-links collagen in the cornea, thereby stiffening it and often flattening extremely steep curvatures.

Read More